References

An anomalous mottled rash, accompanied by pruritus, factious urticaria and pigmentation, urticaria pigmentosa

1878 · External reference

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

10.1016/j.jaci.2015.08.034 · 2016 · External reference

The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions

10.1016/j.jaip.2013.09.004 · 2014 · External reference

Paediatric mastocytosis: a systematic review of 1747 cases

10.1111/bjd.13567 · 2015 · External reference

Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients

10.1111/j.1398-9995.2007.01569.x · 2008 · External reference

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

10.1016/j.jaci.2013.06.020 · 2014 · External reference

Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal

10.1097/hs9.0000000000000646 · 2021 · External reference

Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management

10.1016/j.jaip.2019.02.002 · 2019 · External reference

Mastocytosis

10.1038/s41572-025-00611-8 · 2025 · External reference

Clinical aspects of diffuse cutaneous mastocytosis in children: two variants

10.1159/000243808 · 2009 · External reference

Pediatric mastocytosis

10.1016/s0889-8588(05)70299-9 · 2000 · External reference

Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice

10.1111/exd.12463 · 2014 · External reference

Activation and function of the mTORC1 pathway in mast cells

10.4049/jimmunol.180.7.4586 · 2008 · External reference

Regulation of mast cell survival and function by tuberous sclerosis complex 1

10.1182/blood-2011-05-353342 · 2012 · External reference

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

10.1182/blood-2005-06-2433 · 2006 · External reference

Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis

10.1111/ced.12000 · 2013 · External reference

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

10.1182/blood-2011-06-359984 · 2011 · External reference

Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis

10.1046/j.1365-2133.2003.05598.x · 2003 · External reference

Epidemiology of mastocytosis: a population-based study (Sweden)

10.2340/1651-226x.2024.31406 · 2024 · External reference

Epidemiology of systemic mastocytosis in Denmark

10.1111/bjh.12916 · 2014 · External reference

Mastocytosis

10.1016/j.iac.2013.09.001 · 2014 · External reference

10.1007/978-3-030-27820-5_2

10.1007/978-3-030-27820-5_2 · 2020 · External reference

10.1007/978-3-642-71524-2_20

10.1007/978-3-642-71524-2_20 · 1987 · External reference

Management of Mastocytosis and Mast Cell Activation in Children

10.1016/j.jaip.2025.11.016 · 2026 · External reference

A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity

10.1111/j.1365-2133.2011.10471.x · 2011 · External reference

Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells

10.1038/sj.onc.1201341 · 1997 · External reference

Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways

10.1016/j.canlet.2015.01.043 · 2015 · External reference

Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor

10.1084/jem.187.10.1565 · 1998 · External reference